NCT02946541View on ClinicalTrials.gov

A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

April 30, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

evogliptin 5mg

evogliptin 5mg, QD

DRUG

Placebo

Placebo, QD

Trial Locations (1)

134-701

Kangdong Sacred Heart Hospital, Seoul

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02946541 - A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin | Biotech Hunter | Biotech Hunter